Advances in immunotherapy for pancreatic ductal adenocarcinoma
Author:
Affiliation:
1. Second Department of Surgery School of Medicine Wakayama Medical University Wakayama Japan
Publisher
Wiley
Subject
Hepatology,Surgery
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jhbp.944
Reference99 articles.
1. Cancer statistics, 2020
2. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
3. Classifying Cancers Based on T-cell Infiltration and PD-L1
4. The Next Hurdle in Cancer Immunotherapy: Overcoming the Non–T-Cell–Inflamed Tumor Microenvironment
5. Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Transforming pancreaticobiliary cancer treatment: Exploring the frontiers of adoptive cell therapy and cancer vaccines;Molecular Therapy: Oncology;2024-09
2. Harnessing innate immune pathways for therapeutic advancement in cancer;Signal Transduction and Targeted Therapy;2024-03-25
3. Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of Immunotherapy and Spikes of Lights;Current Oncology;2023-03-30
4. Perioperative oncolytic virotherapy to counteract surgery-induced immunosuppression and improve outcomes in pancreatic ductal adenocarcinoma;Frontiers in Oncology;2023-02-16
5. Introduction to Cancer Treatment;Handbook of Cancer and Immunology;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3